Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CEINGE-Biotecnologie Avanzate is a prominent non-profit research and diagnostic center based in Naples, Italy, dedicated to molecular biology and advanced biotechnology. It operates as a consortium involving the University of Naples Federico II and other public entities, focusing on the study of genetic diseases, oncology, and the development of novel therapeutic approaches. The center provides high-tech diagnostic services for the national health system and hosts numerous research labs equipped with cutting-edge platforms for genomics, proteomics, and bioinformatics. CEINGE also plays a vital role in high-level scientific training and technology transfer, bridging the gap between basic research and clinical applications. Its multidisciplinary environment supports the discovery of biomarkers and the validation of new drug targets for rare and common diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CEINGE-Biotecnologie Avanzate.